Clinical trial
Photodynamic Therapy in Occult-Only Lesions (POOL)
NCT00135837 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00135837 |
|---|---|
| Title | Photodynamic Therapy in Occult-Only Lesions (POOL) |
| Official title | An Open-Label, Multicenter, Phase 4 Study of the Effect of Verteporfin for Injection Therapy in Subjects With Occult With No Classic Choroidal NeoVascularization Secondary to Age-Related Macular Degeneration |
| Lead sponsor | Novartis, Industry |
| Collaborators | QLT Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | Verteporfin for injection |
| Enrollment | 202 |
| Start date | Jun 1, 2003 |
| First posted | Aug 26, 2005 |
| Last update posted | Jun 21, 2006 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: